# TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma

> **NCT01833286** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 200 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Surgery
- Ablation

## Interventions

- **PROCEDURE:** TACE+RFA
- **PROCEDURE:** re-resection

## Key facts

- **NCT ID:** NCT01833286
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2017-07
- **Final completion:** 2019-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01833286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01833286, "TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01833286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*